Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Mid-Pleistocene transition in glacial cycles explained by declining CO2 and regolith removal.

Willeit M, Ganopolski A, Calov R, Brovkin V.

Sci Adv. 2019 Apr 3;5(4):eaav7337. doi: 10.1126/sciadv.aav7337. eCollection 2019 Apr.

2.

Molar activity - The keystone in 11C-radiochemistry: An explorative study using the gas phase method.

Pichler V, Zenz T, Philippe C, Vraka C, Berrotéran-Infante N, Pfaff S, Nics L, Ozenil M, Langer O, Willeit M, Traub-Weidinger T, Lanzenberger R, Mitterhauser M, Hacker M, Wadsak W.

Nucl Med Biol. 2018 Dec;67:21-26. doi: 10.1016/j.nucmedbio.2018.09.003. Epub 2018 Oct 12.

PMID:
30380463
3.

Rapid antidepressant effect of S-ketamine in schizophrenia.

Bartova L, Papageorgiou K, Milenkovic I, Dold M, Weidenauer A, Willeit M, Winkler D, Kasper S.

Eur Neuropsychopharmacol. 2018 Aug;28(8):980-982. doi: 10.1016/j.euroneuro.2018.05.007. Epub 2018 Jul 2.

PMID:
30041987
4.

DiGeorge syndrome : Relevance of psychiatric symptoms in undiagnosed adult patients.

Kraus C, Vanicek T, Weidenauer A, Khanaqa T, Stamenkovic M, Lanzenberger R, Willeit M, Kasper S.

Wien Klin Wochenschr. 2018 Apr;130(7-8):283-287. doi: 10.1007/s00508-018-1335-y. Epub 2018 Apr 18.

5.

The effect of seasonal changes and climatic factors on suicide attempts of young people.

Akkaya-Kalayci T, Vyssoki B, Winkler D, Willeit M, Kapusta ND, Dorffner G, Özlü-Erkilic Z.

BMC Psychiatry. 2017 Nov 15;17(1):365. doi: 10.1186/s12888-017-1532-7.

6.

Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.

Bartova L, Weidenauer A, Dold M, Naderi-Heiden A, Kasper S, Willeit M, Praschak-Rieder N.

J ECT. 2017 Sep;33(3):e31-e32. doi: 10.1097/YCT.0000000000000421. No abstract available.

PMID:
28520578
7.

Administration of ketamine for unipolar and bipolar depression.

Kraus C, Rabl U, Vanicek T, Carlberg L, Popovic A, Spies M, Bartova L, Gryglewski G, Papageorgiou K, Lanzenberger R, Willeit M, Winkler D, Rybakowski JK, Kasper S.

Int J Psychiatry Clin Pract. 2017 Mar;21(1):2-12. doi: 10.1080/13651501.2016.1254802. Epub 2017 Jan 18. Review. Erratum in: Int J Psychiatry Clin Pract. 2017 Jun;21(2):161.

PMID:
28097909
8.

Introduction to the Special Issue on dopamine celebrating the 90th birthday of Oleh Hornykiewicz.

Sitte H, Willeit M.

Eur J Neurosci. 2017 Jan;45(1):1. doi: 10.1111/ejn.13502. No abstract available.

PMID:
28044407
9.

Pregabalin in Tourette's Syndrome: A Case Series.

Hienert M, Weidenauer A, Kraus C, Willeit M, Kasper S, Stamenkovic M.

Am J Psychiatry. 2016 Dec 1;173(12):1242-1243. No abstract available.

PMID:
27903096
10.

Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence.

Sauerzopf U, Sacco R, Novarino G, Niello M, Weidenauer A, Praschak-Rieder N, Sitte H, Willeit M.

Eur J Neurosci. 2017 Jan;45(1):45-57. doi: 10.1111/ejn.13418. Epub 2016 Oct 19. Review.

11.

Case Report: ECT in a Patient With Primary Parkinsonian Syndrome and Schizophrenia.

Baldinger-Melich P, Weidenauer A, Linder C, Hienert M, Kasper S, Stamenkovic M, Willeit M.

J ECT. 2017 Mar;33(1):e2-e3. doi: 10.1097/YCT.0000000000000363. No abstract available.

PMID:
27753758
12.

Has the existence of seasonal affective disorder been disproven?

Winkler D, Pjrek E, Spies M, Willeit M, Dorffner G, Lanzenberger R, Kasper S.

J Affect Disord. 2017 Jan 15;208:54-55. doi: 10.1016/j.jad.2016.08.041. Epub 2016 Oct 3. No abstract available.

PMID:
27744127
13.

Making Sense of: Sensitization in Schizophrenia.

Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Praschak-Rieder N, Sitte HH, Kasper S, Willeit M.

Int J Neuropsychopharmacol. 2016 Dec 31;20(1):1-10. doi: 10.1093/ijnp/pyw081. Print 2017 Jan. Review.

14.

Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases.

Bartova L, Vogl SE, Stamenkovic M, Praschak-Rieder N, Naderi-Heiden A, Kasper S, Willeit M.

Eur Neuropsychopharmacol. 2015 Nov;25(11):2183-4. doi: 10.1016/j.euroneuro.2015.07.021. Epub 2015 Aug 6.

PMID:
26302763
15.

Direct effect of sunshine on suicide.

Vyssoki B, Kapusta ND, Praschak-Rieder N, Dorffner G, Willeit M.

JAMA Psychiatry. 2014 Nov;71(11):1231-7. doi: 10.1001/jamapsychiatry.2014.1198.

PMID:
25208208
16.

In vivo amphetamine action is contingent on αCaMKII.

Steinkellner T, Mus L, Eisenrauch B, Constantinescu A, Leo D, Konrad L, Rickhag M, Sørensen G, Efimova EV, Kong E, Willeit M, Sotnikova TD, Kudlacek O, Gether U, Freissmuth M, Pollak DD, Gainetdinov RR, Sitte HH.

Neuropsychopharmacology. 2014 Oct;39(11):2681-93. doi: 10.1038/npp.2014.124. Epub 2014 May 29.

17.

Platelet serotonin transporter function predicts default-mode network activity.

Scharinger C, Rabl U, Kasess CH, Meyer BM, Hofmaier T, Diers K, Bartova L, Pail G, Huf W, Uzelac Z, Hartinger B, Kalcher K, Perkmann T, Haslacher H, Meyer-Lindenberg A, Kasper S, Freissmuth M, Windischberger C, Willeit M, Lanzenberger R, Esterbauer H, Brocke B, Moser E, Sitte HH, Pezawas L.

PLoS One. 2014 Mar 25;9(3):e92543. doi: 10.1371/journal.pone.0092543. eCollection 2014.

18.

Reliable set-up for in-loop ¹¹C-carboxylations using Grignard reactions for the preparation of [carbonyl-¹¹C]WAY-100635 and [¹¹C]-(+)-PHNO.

Rami-Mark C, Ungersboeck J, Haeusler D, Nics L, Philippe C, Mitterhauser M, Willeit M, Lanzenberger R, Karanikas G, Wadsak W.

Appl Radiat Isot. 2013 Dec;82:75-80. doi: 10.1016/j.apradiso.2013.07.023. Epub 2013 Aug 3.

19.

Is dopamine neurotransmission altered in prodromal schizophrenia? A review of the evidence.

Bauer M, Praschak-Rieder N, Kasper S, Willeit M.

Curr Pharm Des. 2012;18(12):1568-79. Review.

PMID:
22280434
20.

Imaging of seasonal affective disorder and seasonality effects on serotonin and dopamine function in the human brain.

Praschak-Rieder N, Willeit M.

Curr Top Behav Neurosci. 2012;11:149-67. doi: 10.1007/7854_2011_174.

PMID:
22218931
21.

Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy.

Vossen MG, Gattringer KB, Khalifeh N, Koreny M, Spertini V, Mallouhi A, Willeit M, Volc-Platzer B, Asboth F, Graninger W, Thalhammer F, Lagler H.

J Clin Microbiol. 2012 Mar;50(3):1109-12. doi: 10.1128/JCM.06161-11. Epub 2011 Dec 21.

22.

Light-dependent alteration of serotonin-1A receptor binding in cortical and subcortical limbic regions in the human brain.

Spindelegger C, Stein P, Wadsak W, Fink M, Mitterhauser M, Moser U, Savli M, Mien LK, Akimova E, Hahn A, Willeit M, Kletter K, Kasper S, Lanzenberger R.

World J Biol Psychiatry. 2012 Sep;13(6):413-22. doi: 10.3109/15622975.2011.630405. Epub 2011 Nov 23.

PMID:
22111663
23.

Effects of sunshine on suicide rates.

Vyssoki B, Praschak-Rieder N, Sonneck G, Blüml V, Willeit M, Kasper S, Kapusta ND.

Compr Psychiatry. 2012 Jul;53(5):535-9. doi: 10.1016/j.comppsych.2011.06.003. Epub 2011 Aug 6.

PMID:
21821241
24.

Bright-light therapy in the treatment of mood disorders.

Pail G, Huf W, Pjrek E, Winkler D, Willeit M, Praschak-Rieder N, Kasper S.

Neuropsychobiology. 2011;64(3):152-62. doi: 10.1159/000328950. Epub 2011 Jul 29. Review.

25.

Lithium in drinking water and suicide mortality.

Kapusta ND, Mossaheb N, Etzersdorfer E, Hlavin G, Thau K, Willeit M, Praschak-Rieder N, Sonneck G, Leithner-Dziubas K.

Br J Psychiatry. 2011 May;198(5):346-50. doi: 10.1192/bjp.bp.110.091041.

PMID:
21525518
26.

Inpatient treatment of major depression in Austria between 1989 and 2009: impact of downsizing of psychiatric hospitals on admissions, suicide rates and outpatient psychiatric services.

Vyssoki B, Willeit M, Blüml V, Höfer P, Erfurth A, Psota G, Lesch OM, Kapusta ND.

J Affect Disord. 2011 Sep;133(1-2):93-6. doi: 10.1016/j.jad.2011.03.031. Epub 2011 Apr 16.

PMID:
21497914
27.

Aberrant Effective Connectivity in Schizophrenia Patients during Appetitive Conditioning.

Diaconescu AO, Jensen J, Wang H, Willeit M, Menon M, Kapur S, McIntosh AR.

Front Hum Neurosci. 2011 Jan 17;4:239. doi: 10.3389/fnhum.2010.00239. eCollection 2011.

28.

Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry.

Willeit M, Praschak-Rieder N.

Neuroimage. 2010 Nov 15;53(3):878-92. doi: 10.1016/j.neuroimage.2010.04.030. Epub 2010 Apr 23. Review.

PMID:
20399868
29.

Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis.

Pjrek E, Konstantinidis A, Assem-Hilger E, Praschak-Rieder N, Willeit M, Kasper S, Winkler D.

J Psychiatr Res. 2009 May;43(8):792-7. doi: 10.1016/j.jpsychires.2008.11.004. Epub 2009 Feb 23.

PMID:
19230909
30.

Seasonal variation in human brain serotonin transporter binding.

Praschak-Rieder N, Willeit M, Wilson AA, Houle S, Meyer JH.

Arch Gen Psychiatry. 2008 Sep;65(9):1072-8. doi: 10.1001/archpsyc.65.9.1072.

PMID:
18762593
31.

Treatment of seasonal affective disorder with duloxetine: an open-label study.

Pjrek E, Willeit M, Praschak-Rieder N, Konstantinidis A, Semlitsch HV, Kasper S, Winkler D.

Pharmacopsychiatry. 2008 May;41(3):100-5. doi: 10.1055/s-2008-1058103.

PMID:
18484551
32.

Season of birth in siblings of patients with seasonal affective disorder. A test of the parental conception habits hypothesis.

Pjrek E, Winkler D, Praschak-Rieder N, Willeit M, Stastny J, Konstantinidis A, Kasper S.

Eur Arch Psychiatry Clin Neurosci. 2007 Oct;257(7):378-82.

PMID:
17902009
33.

Enhanced serotonin transporter function during depression in seasonal affective disorder.

Willeit M, Sitte HH, Thierry N, Michalek K, Praschak-Rieder N, Zill P, Winkler D, Brannath W, Fischer MB, Bondy B, Kasper S, Singer EA.

Neuropsychopharmacology. 2008 Jun;33(7):1503-13. Epub 2007 Sep 19.

34.

Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.

Graff-Guerrero A, Willeit M, Ginovart N, Mamo D, Mizrahi R, Rusjan P, Vitcu I, Seeman P, Wilson AA, Kapur S.

Hum Brain Mapp. 2008 Apr;29(4):400-10.

PMID:
17497628
35.

The formation of abnormal associations in schizophrenia: neural and behavioral evidence.

Jensen J, Willeit M, Zipursky RB, Savina I, Smith AJ, Menon M, Crawley AP, Kapur S.

Neuropsychopharmacology. 2008 Feb;33(3):473-9. Epub 2007 May 2.

36.

First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study.

Willeit M, Ginovart N, Graff A, Rusjan P, Vitcu I, Houle S, Seeman P, Wilson AA, Kapur S.

Neuropsychopharmacology. 2008 Jan;33(2):279-89. Epub 2007 Apr 4.

37.

Escitalopram in seasonal affective disorder: results of an open trial.

Pjrek E, Winkler D, Stastny J, Praschak-Rieder N, Willeit M, Kasper S.

Pharmacopsychiatry. 2007 Jan;40(1):20-4.

PMID:
17327956
38.

Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study.

Praschak-Rieder N, Kennedy J, Wilson AA, Hussey D, Boovariwala A, Willeit M, Ginovart N, Tharmalingam S, Masellis M, Houle S, Meyer JH.

Biol Psychiatry. 2007 Aug 15;62(4):327-31. Epub 2007 Jan 8.

PMID:
17210141
39.

Agomelatine in the treatment of seasonal affective disorder.

Pjrek E, Winkler D, Konstantinidis A, Willeit M, Praschak-Rieder N, Kasper S.

Psychopharmacology (Berl). 2007 Mar;190(4):575-9. Epub 2006 Dec 15.

PMID:
17171557
40.

Serum lipid levels in seasonal affective disorder.

Pjrek E, Winkler D, Abramson DW, Konstantinidis A, Stastny J, Willeit M, Praschak-Rieder N, Kasper S.

Eur Arch Psychiatry Clin Neurosci. 2007 Jun;257(4):197-202. Epub 2006 Dec 5.

PMID:
17149538
41.

Positron emission tomography quantification of [11C]-(+)-PHNO binding in the human brain.

Ginovart N, Willeit M, Rusjan P, Graff A, Bloomfield PM, Houle S, Kapur S, Wilson AA.

J Cereb Blood Flow Metab. 2007 Apr;27(4):857-71. Epub 2006 Oct 11.

PMID:
17033687
42.

Separate brain regions code for salience vs. valence during reward prediction in humans.

Jensen J, Smith AJ, Willeit M, Crawley AP, Mikulis DJ, Vitcu I, Kapur S.

Hum Brain Mapp. 2007 Apr;28(4):294-302.

PMID:
16779798
43.

Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.

Ginovart N, Galineau L, Willeit M, Mizrahi R, Bloomfield PM, Seeman P, Houle S, Kapur S, Wilson AA.

J Neurochem. 2006 May;97(4):1089-103. Epub 2006 Apr 5.

44.

High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO.

Willeit M, Ginovart N, Kapur S, Houle S, Hussey D, Seeman P, Wilson AA.

Biol Psychiatry. 2006 Mar 1;59(5):389-94. Epub 2005 Dec 20.

PMID:
16373068
45.

A Cys 23-Ser 23 substitution in the 5-HT(2C) receptor gene influences body weight regulation in females with seasonal affective disorder: an Austrian-Canadian collaborative study.

Praschak-Rieder N, Willeit M, Zill P, Winkler D, Thierry N, Konstantinidis A, Masellis M, Basile VS, Bondy B, Ackenheil M, Neumeister A, Kaplan AS, Kennedy JL, Kasper S, Levitan R.

J Psychiatr Res. 2005 Nov;39(6):561-7. Epub 2005 Apr 26.

PMID:
16157158
46.

Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy.

Winkler D, Pjrek E, Praschak-Rieder N, Willeit M, Pezawas L, Konstantinidis A, Stastny J, Kasper S.

Biol Psychiatry. 2005 Aug 15;58(4):331-6.

PMID:
16102546
47.

Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.

Seeman P, Ko F, Willeit M, McCormick P, Ginovart N.

Synapse. 2005 Nov;58(2):122-8.

PMID:
16088951
48.

Anger attacks in seasonal affective disorder.

Winkler D, Pjrek E, Konstantinidis A, Praschak-Rieder N, Willeit M, Stastny J, Kasper S.

Int J Neuropsychopharmacol. 2006 Apr;9(2):215-9. Epub 2005 Jul 8.

PMID:
16004620
49.
50.

Seasonality of birth in seasonal affective disorder.

Pjrek E, Winkler D, Heiden A, Praschak-Rieder N, Willeit M, Konstantinidis A, Stastny J, Kasper S.

J Clin Psychiatry. 2004 Oct;65(10):1389-93.

PMID:
15491243

Supplemental Content

Loading ...
Support Center